A recent article claiming that AI-driven cancer research is being hampered by the global chip shortage has met with significant skepticism on Hacker News. Users largely dismissed the premise as a cynical attempt by the CEO of Arm to manufacture demand for hardware. Commenters mocked the narrative, comparing it to other hyperbolic corporate claims and questioning why AI, which is purportedly nearing AGI-level capabilities, cannot overcome these infrastructure constraints itself. The discussion quickly devolved into broader critiques of the current "AI gold rush," with participants expressing frustration over the discrepancy between the industry's grand promises—such as curing cancer—and the underwhelming reality of AI's current utility in fields like software development. Overall, the community views the report as a transparent marketing tactic rather than a genuine obstacle to medical progress.